Article Text

Download PDFPDF
Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
  1. Alberto Dominguez-Rodriguez1,2,
  2. Pedro Abreu-Gonzalez3,
  3. Russel J Reiter4
  1. 1Department of Cardiology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
  2. 2Facultad de Ciencias de la Salud, Universidad Europea de Canarias, La Orotava, Santa Cruz de Tenerife, Spain
  3. 3Departamento de Ciencias Médicas Básicas (Unidad de Fisiología), Universidad de La Laguna, Santa Cruz de Tenerife, Spain
  4. 4Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas, USA
  1. Correspondence to Dr Alberto Dominguez-Rodriguez, Department of Cardiology, Hospital Universitario de Canarias, Ofra s/n La Cuesta, Santa Cruz de Tenerife E-38320, Spain; adrvdg{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Melatonin, an endocrine product of the pineal gland, is formed predominantly during the nighttime. Light has an inhibitory effect on pineal melatonin secretion. Pineal melatonin release is synchronised by this daily light-dark cycle via a multisynaptic pathway between the eyes and the pineal gland. Light stimulates the retina to modulate the activity of the suprachiasmatic nucleus, the master biological clock.1 The suprachiasmatic nucleus controls pineal melatonin synthesis and the concentrations of melatonin in the sera of healthy subjects, which reach values of 10−10 to 10−9 mol/L during the night, with much lower concentrations being present during the day. Many publications have shown that melatonin has an important role in a variety of cardiovascular pathophysiologic processes: the indoleamine has anti-inflammatory, antioxidant, antihypertensive, antithrombotic and antilipaemic properties1 (figure 1).

Figure 1

The properties of melatonin and the effects on multiple organs.

In their Heart manuscript, McMullan et al2 report their findings when analysing data from the Nurses's Health Study I (NHS I) and NHS II to investigate the independent association of nocturnal melatonin secretion with the incidence of myocardial infarction (MI). In accordance with the authors, the NHS I began in 1976, with 121 701 registered nurses aged 30–55 years returning an initial questionnaire; the NHS II began in 1989 with 116 430 female registered nurses. In the initial and subsequent biennial questionnaires, health status, medications, dietary intake and lifestyle factors, including smoking history, physical activity and sleeping patterns, were ascertained. In addition to completing questionnaires, blood and urine samples were provided by 18 743 women between 1999 and 2000 in NHS I …

View Full Text


  • Contributors AD-R, PA-G and RJR conceived and designed the commissioned Editorial.

  • Funding This editorial was supported by Institute Carlos III (ISCIII) (PI15/01260), General Branch Evaluation and Research Promotion, State Plan of Scientific and Technical Research and Innovation 2013–2016 and European Regional Development Fund Health—FEDER, which relates to the topic of this study.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles